Stocks · Health care · Pharmaceutical Preparations

TALPHERA, INC.

TLPH Clue Score41
United States Fiscal year ends December CIK 0001427925 Results filed 12 Aug 2026

What the insiders did Net buying

By person

11 insiders · 5 transactions
0.6×

Vincent J. Angotti holds only 0.6 times base salary in stock. $463.39K of shares against $688.81K in salary for 2025.

Salary from the company's own proxy. The shares are what Vincent J. Angotti last reported holding, valued at $0.59, the price Common Stock was last bought or sold at on the open market here, on 13 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Vincent J. Angotti
Chief Executive Officer
$210.59K (2)
—
+$210.59K
790,767
$463.39K
+246.7%
Raffi Asadorian
Chief Financial Officer
$36.55K (1)
—
+$36.55K
85,879
$50.33K
+127.6%
Shakil Aslam
Chief Medical Officer
$28.43K (1)
—
+$28.43K
76,542
$44.85K
+103.1%
Badri N Dasu
Chief Engineering Officer
$28.43K (1)
—
+$28.43K
71,440
$41.86K
+127.4%
Adrian Adams
Director
—
—
—
22,709
$13.31K
+70.2%
Marina Bozilenko
Director
—
—
—
14,147
$8.29K
+196.0%
Mark A Wan
Director
—
—
—
13,959
$8.18K
+204.0%
Stephen J Hoffman
Director
—
—
—
13,959
$8.18K
+204.0%
Jill Marie Broadfoot
Director
—
—
—
13,647
$8.00K
+218.9%
Abhinav Jain
Director
—
—
—
12,412
$7.27K
+307.6%
Joseph Todisco
Director
—
—
—
11,497
$6.74K
—

No percentages here. This company's share count has moved by a factor of 3.0 over the window, from 17,098,345 to 51,905,796 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.